open access

Vol 15, No 5 (2011)
Artykuły redakcyjne
Published online: 2011-12-13
Get Citation

Hypertension as a risk factor for heart failure

Kalina Kawecka-Jaszcz, Małgorzata Kloch-Badełek, Wiktoria Wojciechowska
Nadciśnienie tętnicze 2011;15(5):275-282.

open access

Vol 15, No 5 (2011)
Artykuły redakcyjne
Published online: 2011-12-13

Abstract

Heart failure clinical syndrome arising from any structural or functional cardiac condition is associated with a comparable number of expected life-years lost as many common types of cancer and is one of the major health care problems worldwide.
Heart failure represents the final common pathway of the clinical history of different cardiac diseases. Arterial hypertension has been long considered as one of the most common etiological conditions predisposing to the development of heart failure. Clinical studies showed that different antihypertensive strategies reduced the incidence of heart failure in hypertensive patients.
Hypertension can lead to left ventricle hypertrophy, diastolic or systolic dysfunction and overt heart failure. The remodeling of left ventricle can cause diastolic dysfunction without clinical signs or symptoms of heart failure. The results at our center show that age-specific criteria for diastolic left ventricle dysfunction were highly consistent across populations with an age-standardized prevalence of 22.4% v. 25.1% (p = 0.09). This emphasizes the importance of treatment in some patients prior to development of overt heart failure.
Diastolic heart failure is characterized by the symptoms and signs, a preserved ejection fraction and abnormal left ventricular diastolic function caused by a decreased left ventricle compliance and relaxation.
Hypertension with other risk factors for atherosclerosis may cause myocardial infarction. Post MI remodeling takes place, leading to systolic dysfunction. Progression will lead to heart failure, with decreasing ejection fraction. The majority of patients with heart failure and preserved ejection fraction have a history of hypertension. Hypertension induces a compensatory thickening of the ventricular wall in an attempt to normalize wall stress, which results in left ventricle concentric hypertrophy, which in turn decreases left ventricle compliance and left ventricle diastolic filling. There are no specific guidelines for treating diastolic heart failure, but pharmacological treatment should be directed at normalizing blood pressure, promoting regression of left ventricle hypertrophy, preventing tachycardia and treating symptoms of congestion.
Preventive strategies directed toward an early and aggressive blood pressure control are likely to offer the greatest promise for reducing the incidence of heart failure.
Arterial Hypertension 2011, vol. 15, no 5, pages 275–282

Abstract

Heart failure clinical syndrome arising from any structural or functional cardiac condition is associated with a comparable number of expected life-years lost as many common types of cancer and is one of the major health care problems worldwide.
Heart failure represents the final common pathway of the clinical history of different cardiac diseases. Arterial hypertension has been long considered as one of the most common etiological conditions predisposing to the development of heart failure. Clinical studies showed that different antihypertensive strategies reduced the incidence of heart failure in hypertensive patients.
Hypertension can lead to left ventricle hypertrophy, diastolic or systolic dysfunction and overt heart failure. The remodeling of left ventricle can cause diastolic dysfunction without clinical signs or symptoms of heart failure. The results at our center show that age-specific criteria for diastolic left ventricle dysfunction were highly consistent across populations with an age-standardized prevalence of 22.4% v. 25.1% (p = 0.09). This emphasizes the importance of treatment in some patients prior to development of overt heart failure.
Diastolic heart failure is characterized by the symptoms and signs, a preserved ejection fraction and abnormal left ventricular diastolic function caused by a decreased left ventricle compliance and relaxation.
Hypertension with other risk factors for atherosclerosis may cause myocardial infarction. Post MI remodeling takes place, leading to systolic dysfunction. Progression will lead to heart failure, with decreasing ejection fraction. The majority of patients with heart failure and preserved ejection fraction have a history of hypertension. Hypertension induces a compensatory thickening of the ventricular wall in an attempt to normalize wall stress, which results in left ventricle concentric hypertrophy, which in turn decreases left ventricle compliance and left ventricle diastolic filling. There are no specific guidelines for treating diastolic heart failure, but pharmacological treatment should be directed at normalizing blood pressure, promoting regression of left ventricle hypertrophy, preventing tachycardia and treating symptoms of congestion.
Preventive strategies directed toward an early and aggressive blood pressure control are likely to offer the greatest promise for reducing the incidence of heart failure.
Arterial Hypertension 2011, vol. 15, no 5, pages 275–282
Get Citation

Keywords

arterial hypertension; left ventricular hypertrophy; diastolic dysfunction; systolic heart failure

About this article
Title

Hypertension as a risk factor for heart failure

Journal

Arterial Hypertension

Issue

Vol 15, No 5 (2011)

Pages

275-282

Published online

2011-12-13

Bibliographic record

Nadciśnienie tętnicze 2011;15(5):275-282.

Keywords

arterial hypertension
left ventricular hypertrophy
diastolic dysfunction
systolic heart failure

Authors

Kalina Kawecka-Jaszcz
Małgorzata Kloch-Badełek
Wiktoria Wojciechowska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl